All it takes is one hit piece. For some reason I thought it would be different this time. Similar to ONVO and INO, and now KNDI for the second time. I agree that long term we will do well. I have a large stake and am doing my best to hold, tough to watch all gains go away, but that's the game. To me, the chart looks like a range of 16 to 18 for a while and then a pop into new highs. Of course manipulation could change that.
Most are probably tired of the games. I know I am. Typical market manipulation by crooks to knock it down just like every stock that gets a run lately, followed by a week of intense bashing and intense pumping. The stock is getting tired. Hopefully it floats in this range instead of crashing back to lows like last time. I know a PR from the company would do wonders.
Just started investing end of 2013. I see countless stocks from last year that just climbed all year. Everytime i get a decent run on something, these hit pieces tear away my gains and sometimes turn to losses. Happened KNDI, ONVO, INO, and others. How did so many stocks just run in 2013? since I've started, no matter how good a company, these people come up with something and the street reacts to an extreme. It's like clockwork.
Same boat, bought at 14 and held through last pop to 22 to watch all my gains go and then turn to loss down to 10, I feel there is more support this time and the company is proving itself, but I'm never comfortable after that until this thing hits 25 plus. Sold some yesterday and waiting for reentry.
Agreed. Perfect cup, i sold some and am looking to pick back up in 18's on the handle before hitting new highs. Hard to be patient knowing it may not get that low. See what tomorrow brings.
Being new to biotech, what are we expecting from the trial update. I understand that it did not meet secondary endpoints, but there were some other improvements noted, are we waiting for an announcement of another phase II trial to be conducted with different expectations, or a phase III trial using the positive data from phase II for a different type of treatment? I'm not quite sure how it works. What are some possible catalysts from this update news. Its great that there were some other positive responses to this drug, but where does that take us being that it failed the phase II trials for what it was intended for. Any help would be appreciated.
Can anyone validate for sure if Purdue version contains acetaminophen? I thought that it did, which if that is the case, then there is no comparison. The whole idea behind zohydro is ACETAMINOPHEN free. Why is this never mentioned????
Every biotech i've bought in the last 6 months has dropped below dilution price eventually. Looking for 3.90 buy in. No matter how good i thought the company was or how much i was sure it was holding, they all hit it and then some.
I'm in the same boat. my average price is .82, I also own INO at average 3.25. I bought in at the peak of these damn stocks on all the hype and they are the worst ones in my portfolios but unfortunately the largest positions. i doubled my position before the ASCO and now am sick, but I am still holding and if this gets below 50, i will sell my INO beating and throw it into ONCS because I feel i have a better chance here.
This is the most manipulated stock I've ever seen. We don't have many overall green days lately, and this goes red everytime, even with good news. For a company with such potential and a great year so far, I can't believe I am under water still. And you can gaurantee on market down days this stock will tank. As much as I believe in this company and future, wishing I never bought into it with the way it's being manipulated by crooks
how long this SEC #$%$ will take? It's getting really old. Let's get it over and done with, are they going to keep pumping these scare articles for years? I personally don't really care if there was a bit of crooked activity, most companies are crooked, just some get called on it. That doesn't change the fact that this company has a huge future and a great product. What's it gonna take to stop getting beaten down?
More dilution now? I thought the dilution at 2.90 wasn't even needed but was to get a safety net of cash? Is this guy trying to absolutely shake out and shatter confidence of every retail investor. How about throwing the small shareholders who invest in your company a bone huh?
Here we go again, haven't they beaten this one enough? Give it up, we get a 10% gain and they have to try to steal it back everytime. How about going after some other companies, like say DARA which jumped 100% today on absolutely no news. Unbelievable the determination to keep this down.
Who get caught in a squeeze with this stock deserve it, and I hope they lose big. These greedy thieves have taken this to ridiculous levels and if you haven't covered yet, you deserve what's coming to you.